뒤로
Guangzhou Innogen Pharmaceutical Group Co Ltd(02591.HK) 가격
02591.HK 주가 차트
INNOGEN-B (02591.HK)
Guangzhou Innogen Pharmaceutical Group Co Ltd
HK$27.66
0.94%
$0.26
장 종료: Feb 16, 12:00:00 HKT
주요 통계
이전 종가
$27.6
시가
$27.4
일일 범위
$27.04 - $27.7
52주 범위
$27.66 - $74
거래량
--
평균 거래량
674.8K
EPS(TTM)
-0.54
배당수익률
--
시가총액
$11.6B
INNOGEN-B란 무엇인가요?
Guangzhou Innogen Pharmaceutical Group Co., Ltd. engages in the production and distribution of pharmaceutical products. The company is headquartered in Guangzhou, Guangdong and currently employs 105 full-time employees. The company went IPO on 2025-08-15. The firm is primarily engaged in the commercialization of innovative, humanized, long-acting glucagon-like peptide-1 (GLP-1) receptor agonist. The firm is dedicated to developing therapies for diabetes and other metabolic diseases. The Company’s core product, Efsubaglutide Alfa (brand name: Diabegone), is used for the treatment of type 2 diabetes (T2D). The Company’s primary pipeline drug candidates include YN014, YN401, YN209, YN203, and YN202. The firm principally conducts its businesses in the domestic market.